Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12607000054415
ACTRN12607000054415
Completed
Phase 1

Pharmacokinetic and pharmacodynamic interactions between herbal medicines (cranberry, garlic, echinacea, policosonal, fish oil, CoEnzyme Q10, Soy, feverfew, milk thistle and evening primrose oil) and the anticoagulant warfarin - Randomised clinical trials in healthy male subjects

Prof Andrew McLachlan0 sites60 target enrollmentJanuary 16, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDrug interactions of warfarin with herbal medicines in healthy male subjects. Relevant to Stroke prevention and people receiving warfarinStroke -Other -

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Drug interactions of warfarin with herbal medicines in healthy male subjects. Relevant to Stroke prevention and people receiving warfarin
Sponsor
Prof Andrew McLachlan
Enrollment
60
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 16, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Prof Andrew McLachlan

Eligibility Criteria

Inclusion Criteria

  • •Healthy subjects not taking other medicines including any supplements, who are non\-smokers.

Exclusion Criteria

  • •Any condition with could effect pharmacokinetic and pharmacodynamics of warfarin.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical Pharmacokinetic drug interaction potential of Maha yogaraja Gugglu Tablet(MYG) Tablet in Adult, Healthy, Human volunteers
CTRI/2021/01/030805SRM INSTITUTE OF SCIENCE AND TECHNOLOGY
Completed
Phase 2
Study on the possible pharmacokinetic interaction between grean tea supplements and tamoxifen in patients with breast cancer. the TEA study
NL-OMON48342Erasmus MC, Universitair Medisch Centrum Rotterdam14
Completed
Not Applicable
Study on the possible pharmacokinetic interaction between green tea supplements and tamoxifen in patients with breast cancer. the TEA study”
NL-OMON21997Erasmus MC14
Active, not recruiting
Phase 1
Metabolism and effects of naloxone given as a spray in healthy volunteers and children.Sedation after opioid administrationPharmacokinetic profile after naloxone administered intranasallyTherapeutic area: Body processes [G] - Physical Phenomena [G01]
EUCTR2013-005201-31-SEKarolinska University Hospital20
Completed
Not Applicable
Study on the potential pharmacokinetic interaction between cannabidiol (CBD) and tamoxifen in patients with primary breast cancer
NL-OMON52942Erasmus MC, Universitair Medisch Centrum Rotterdam26